Hao obtained his Master`s Degree in Oncology from Xuzhou Medical University (China) in 2020. He joined ExMI in 2020 as a MD student. The focus of his research is to investigate the impact of fatty acid metabolism on the regulation of tumor immune microenvironment. He is aimed to improve anti-tumor immunity by targeting fatty acid metabolism and apply nanodrug delivery systems to improve treatment selectivity and decrease side-effects. He is also involved in the project of the immunomodulation of chemotherapy.